Paul Andrew Moore - 10 Jan 2025 Form 4 Insider Report for Zymeworks Inc. (ZYME)

Signature
/s/ Daniel Dex, Attorney-in-Fact
Issuer symbol
ZYME
Transactions as of
10 Jan 2025
Net transactions value
$0
Form type
4
Filing time
10 Jan 2025, 18:07:57 UTC
Previous filing
06 Jan 2025
Next filing
05 Jan 2026

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZYME Stock Option (Right to Buy) Award $0 +79,000 $0.000000 79,000 10 Jan 2025 Common Stock 79,000 $13.22 Direct F1
transaction ZYME Restricted Stock Unit Award $0 +53,000 $0.000000 53,000 10 Jan 2025 Common Stock 53,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date.
F2 Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of Issuer's common stock.
F3 RSUs vest in three equal annual installments beginning on first anniversary of grant date.